TY - JOUR
T1 - Short-term Intraocular Pressure Trends After Intravitreal Triamcinolone Injection
AU - Lee, Edward W.
AU - Hariprasad, Seenu M.
AU - Mieler, William F.
AU - Newman, Tricia L.
AU - Apte, Rajendra S.
N1 - Funding Information:
This study was supported by an unrestricted grant from the Research to Prevent Blindness, Inc, New York, New York. The authors indicate no financial conflict of interest. Involved in design of study (E.L., S.H., W.M., R.A.) collection, management, analysis and interpretation of data, and preparation of the data (E.L., S.H., W.M., R.A.); involved in collection of data (E.L., S.H., T.N.); and involved in the review, approval, and preparation of the manuscript (E.L., S.H., T.N., W.M., R.A.).
PY - 2007/2
Y1 - 2007/2
N2 - Purpose: To report the trends in intraocular pressures (IOP) within the first week after intravitreal injection of triamcinolone acetonide (Kenalog) for the treatment of retinal disease. Design: Retrospective chart review. Methods: Review of 43 consecutive patients and 50 intravitreal injections of 4 mg triamcinolone acetonide. Analysis of the effect on IOP was performed. Results: The mean preinjection IOP was 14.60 ± 3.71 mm Hg (mean ± SD) (range, 9 to 26 mm Hg). The mean postinjection IOP (30 minutes after injection) was 19.64 ± 7.43 mm Hg (range, 5 to 45 mm Hg). Mean IOP change before and after injection was 4.83 ± 7.10 mm Hg. The mean IOP one to two days after injection was 15.32 ± 4.41. mm Hg (range, 6 to 27 mm Hg). The mean IOP five to seven days after injection was 15.94 ± 4.86 mm Hg (range, 5 to 28 mm Hg). Conclusions: Intravitreal triamcinolone acetonide injection in this limited series does not cause a marked increase in IOP within the first week after the procedure.
AB - Purpose: To report the trends in intraocular pressures (IOP) within the first week after intravitreal injection of triamcinolone acetonide (Kenalog) for the treatment of retinal disease. Design: Retrospective chart review. Methods: Review of 43 consecutive patients and 50 intravitreal injections of 4 mg triamcinolone acetonide. Analysis of the effect on IOP was performed. Results: The mean preinjection IOP was 14.60 ± 3.71 mm Hg (mean ± SD) (range, 9 to 26 mm Hg). The mean postinjection IOP (30 minutes after injection) was 19.64 ± 7.43 mm Hg (range, 5 to 45 mm Hg). Mean IOP change before and after injection was 4.83 ± 7.10 mm Hg. The mean IOP one to two days after injection was 15.32 ± 4.41. mm Hg (range, 6 to 27 mm Hg). The mean IOP five to seven days after injection was 15.94 ± 4.86 mm Hg (range, 5 to 28 mm Hg). Conclusions: Intravitreal triamcinolone acetonide injection in this limited series does not cause a marked increase in IOP within the first week after the procedure.
UR - http://www.scopus.com/inward/record.url?scp=33846386439&partnerID=8YFLogxK
U2 - 10.1016/j.ajo.2006.08.033
DO - 10.1016/j.ajo.2006.08.033
M3 - Article
C2 - 17258540
AN - SCOPUS:33846386439
SN - 0002-9394
VL - 143
SP - 365
EP - 367
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
IS - 2
ER -